Ondine Biomedical, Inc. (GB:OBI) has released an update.
Ondine Biomedical Inc. has received regulatory approval to launch its Steriwave technology in the UAE, a move that taps into the region’s booming medical tourism industry. The Steriwave system, which uses light-activated agents to eliminate pathogens, offers a promising alternative to antibiotics, particularly against drug-resistant infections in hospitals. This approval could position Ondine at the forefront of infection control in the Middle East’s healthcare sector.
For further insights into GB:OBI stock, check out TipRanks’ Stock Analysis page.
